SCHEMBL30079321

SCHEMBL30079321

COc1nccc(Cl)c1N1CCC(=O)CC1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SUV39H2 Q9H5I1 1/20 0.35
LMNA P02545 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LRRK2 Q5S007 1/20 0.33
DDB1 Q16531 1/20 0.33
CRBN Q96SW2 1/20 0.33
KMT2A Q03164 1/20 0.33
CCR9 P51686 1/20 0.32
KCNJ5 P48544 1/20 0.32
KCNJ3 P48549 1/20 0.32
TP53 P04637 1/20 0.32
NFE2L2 Q16236 1/20 0.32
HRH4 Q9H3N8 1/20 0.31
MALT1 Q9UDY8 1/20 0.31
NPC1 O15118 1/20 0.31
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31
PDE5A O76074 1/20 0.31
CCR4 P51679 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30079304 0.84 C5AR1 (0.41) LMNAALDH1A1DDB1CRBNCCR9
SCHEMBL30079417 0.79 C5AR1 (0.42) LMNAALDH1A1NFE2L2MAPT
SCHEMBL30079474 0.78 HRH3 (0.42) SUV39H2KMT2A
SCHEMBL30079314 0.75 ALDH1A1 (0.41) LMNAALDH1A1KMT2AMAPT
SCHEMBL31266352 0.73 SLC2A1 (0.46) LMNANPC1MAPT
SCHEMBL17893575 0.71 ALDH1A1 (0.44) SUV39H2ALDH1A1LRRK2KMT2AMAPT
SCHEMBL17645550 0.68 HRH4 (0.42) KMT2AHRH4NPC1RAB9ACCR4
SCHEMBL19708748 0.67 TP53 (0.37) SUV39H2LMNAALDH1A1KMT2ATP53
SCHEMBL7492849 0.67 SUV39H2 (0.40) SUV39H2LMNAALDH1A1HRH4
SCHEMBL7489464 0.66 MAPT (0.44) ALDH1A1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3737684-B1 2,4,6,7-TETRAHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-5-ONE DERIVATIVES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS FOR TREATING VASCULITIS AND INFLAMMATORY DISEASES IDORSIA PHARMACEUTICALS LTD (CH) 2022-11-16 EP disclosed